![Petter Lindqvist](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Petter Segelman Lindqvist is currently the Chief Executive Officer at Isofol Medical AB. He previously served as the Chief Executive Officer at Hamlet BioPharma AB. Mr. Lindqvist is a graduate of Stockholm School of Economics.
| Unternehmen | Position | Beginn |
|---|---|---|
| ISOFOL MEDICAL AB | Vorstandsvorsitzender | 09.01.2024 |
| Unternehmen | Position | Ende |
|---|---|---|
| HAMLET PHARMA AB (PUBL) | Vorstandsvorsitzender | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 3 |
|---|---|
Stockholm School of Economics
 Stockholm School of Economics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Isofol Medical AB
 Isofol Medical AB Pharmaceuticals: MajorHealth Technology Provides novel folate-based pharmaceutical products | Health Technology |
Hamlet BioPharma AB
 Hamlet BioPharma AB Pharmaceuticals: MajorHealth Technology Engages in the research and development of pharmaceutical products specifically for cancer patients | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
